Wei‐Hsuan Yu

3.4k total citations
31 papers, 2.8k citations indexed

About

Wei‐Hsuan Yu is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Wei‐Hsuan Yu has authored 31 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 12 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Wei‐Hsuan Yu's work include Protease and Inhibitor Mechanisms (11 papers), Peptidase Inhibition and Analysis (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Wei‐Hsuan Yu is often cited by papers focused on Protease and Inhibitor Mechanisms (11 papers), Peptidase Inhibition and Analysis (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Wei‐Hsuan Yu collaborates with scholars based in United States, Taiwan and Canada. Wei‐Hsuan Yu's co-authors include J. Frederick Woessner, Ivan Stamenkovic, Liliana Ossowski, John D. McNeish, Donald Küfe, Jian Ren, Nicholas Mitsiades, Maria Tsokos, V. Poulaki and Qi Meng and has published in prestigious journals such as Science, Cell and Journal of the American Chemical Society.

In The Last Decade

Wei‐Hsuan Yu

31 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Hsuan Yu United States 17 1.5k 1.1k 974 407 379 31 2.8k
Thomas J. Daly United States 17 2.6k 1.8× 794 0.7× 619 0.6× 240 0.6× 226 0.6× 22 3.6k
Maria Rita Nicotra Italy 42 2.3k 1.6× 577 0.5× 1.3k 1.3× 454 1.1× 491 1.3× 79 4.3k
Michal Safran Israel 31 2.4k 1.7× 954 0.9× 338 0.3× 832 2.0× 277 0.7× 46 3.6k
Terri Davis-Smyth United States 9 3.3k 2.2× 1.2k 1.1× 980 1.0× 250 0.6× 279 0.7× 9 4.8k
Anton Scott Goustin United States 21 2.1k 1.5× 445 0.4× 770 0.8× 362 0.9× 183 0.5× 47 4.0k
Adriana Zanetti Italy 25 1.9k 1.3× 560 0.5× 347 0.4× 598 1.5× 820 2.2× 51 3.2k
Ray B. Nagle United States 34 1.3k 0.9× 421 0.4× 735 0.8× 627 1.5× 631 1.7× 92 3.4k
Takashi Minami Japan 40 3.1k 2.1× 837 0.8× 688 0.7× 397 1.0× 285 0.8× 100 4.7k
Ester Piek Netherlands 27 3.3k 2.2× 491 0.5× 998 1.0× 286 0.7× 309 0.8× 42 4.6k
Hideaki Oda Japan 33 2.1k 1.4× 536 0.5× 613 0.6× 345 0.8× 240 0.6× 105 4.2k

Countries citing papers authored by Wei‐Hsuan Yu

Since Specialization
Citations

This map shows the geographic impact of Wei‐Hsuan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Hsuan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Hsuan Yu more than expected).

Fields of papers citing papers by Wei‐Hsuan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Hsuan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Hsuan Yu. The network helps show where Wei‐Hsuan Yu may publish in the future.

Co-authorship network of co-authors of Wei‐Hsuan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Hsuan Yu. A scholar is included among the top collaborators of Wei‐Hsuan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Hsuan Yu. Wei‐Hsuan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Ming‐Kuem, Yating Yang, Li‐Jen Lin, Wei‐Hsuan Yu, & Huan‐Yuan Chen. (2022). Pulsatilla decoction suppresses matrix metalloproteinase-7-mediated leukocyte recruitment in dextran sulfate sodium-induced colitis mouse model. BMC Complementary Medicine and Therapies. 22(1). 211–211. 3 indexed citations
2.
Yu, Wei‐Hsuan, Erxi Wu, Yongqing Li, et al.. (2020). Matrix Metalloprotease-7 Mediates Nucleolar Assembly and Intra-nucleolar Cleaving p53 in Gefitinib-Resistant Cancer Stem Cells. iScience. 23(10). 101600–101600. 13 indexed citations
4.
Lee, Tsung‐Chun, Yen‐Zhen Lu, Li‐Ling Wu, et al.. (2013). Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice. Gut Pathogens. 5(1). 26–26. 81 indexed citations
5.
Hwang, Juen‐Haur, Chuan‐Jen Hsu, Wei‐Hsuan Yu, Tien‐Chen Liu, & Wei‐Shiung Yang. (2013). Diet-Induced Obesity Exacerbates Auditory Degeneration via Hypoxia, Inflammation, and Apoptosis Signaling Pathways in CD/1 Mice. PLoS ONE. 8(4). e60730–e60730. 56 indexed citations
7.
Chang, Shan‐Chwen, Wei‐Hsuan Yu, Yuwen Wang, et al.. (2009). A Novel Nonsynonymous Variant of Matrix Metalloproteinase-7 Confers Risk of Liver Cirrhosis†. Hepatology. 50(4). 1184–1193. 12 indexed citations
8.
Lu, Dah‐Yuu, Wei‐Hsuan Yu, Wei‐Lan Yeh, et al.. (2009). Hypoxia‐induced matrix metalloproteinase‐13 expression in astrocytes enhances permeability of brain endothelial cells. Journal of Cellular Physiology. 220(1). 163–173. 61 indexed citations
9.
Nye, Jonathon A., David M. Schuster, Wei‐Hsuan Yu, et al.. (2007). Biodistribution and Radiation Dosimetry of the Synthetic Nonmetabolized Amino Acid Analogue Anti-18F-FACBC in Humans. Journal of Nuclear Medicine. 48(6). 1017–1020. 76 indexed citations
10.
Cowper, Diane C., et al.. (2004). Using GIS in Government: An Overview of the VHA's Healthcare Atlas, FY-2000. Journal of Medical Systems. 28(3). 257–269. 5 indexed citations
11.
Ren, Jian, Naoki Agata, Dongshu Chen, et al.. (2004). Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell. 5(2). 163–175. 282 indexed citations
12.
Li, Yongqing, Wen Chen, Jian Ren, et al.. (2003). DF3/MUC1 Signaling In Multiple Myeloma Cells Is Regulated by Interleukin-7. Cancer Biology & Therapy. 2(2). 187–193. 66 indexed citations
13.
Li, Yongqing, Wei‐Hsuan Yu, Jian Ren, et al.. (2003). Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.. PubMed. 1(10). 765–75. 82 indexed citations
14.
Yu, Wei‐Hsuan, J. Frederick Woessner, John D. McNeish, & Ivan Stamenkovic. (2002). CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes & Development. 16(3). 307–323. 363 indexed citations
15.
Yu, Wei‐Hsuan & J. Frederick Woessner. (2001). Heparin-Enhanced Zymographic Detection of Matrilysin and Collagenases. Analytical Biochemistry. 293(1). 38–42. 51 indexed citations
16.
Li, Quan, Hiroaki Kuwahara, Yongqing Li, et al.. (2001). The Epidermal Growth Factor Receptor Regulates Interaction of the Human DF3/MUC1 Carcinoma Antigen with c-Src and β-Catenin. Journal of Biological Chemistry. 276(38). 35239–35242. 227 indexed citations
17.
Mitsiades, Nicholas, Wei‐Hsuan Yu, V. Poulaki, Maria Tsokos, & Ivan Stamenkovic. (2001). Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.. PubMed. 61(2). 577–81. 302 indexed citations
18.
Yu, Wei‐Hsuan, et al.. (2000). TIMP-3 Binds to Sulfated Glycosaminoglycans of the Extracellular Matrix. Journal of Biological Chemistry. 275(40). 31226–31232. 276 indexed citations
19.
Yu, Wei‐Hsuan & J. Frederick Woessner. (2000). Heparan Sulfate Proteoglycans as Extracellular Docking Molecules for Matrilysin (Matrix Metalloproteinase 7). Journal of Biological Chemistry. 275(6). 4183–4191. 202 indexed citations
20.
Yu, Wei‐Hsuan, et al.. (1998). Requirement for Specific Proteases in Cancer Cell Intravasation as Revealed by a Novel Semiquantitative PCR-Based Assay. Cell. 94(3). 353–362. 391 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026